Caitong International Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Sell
1,485
-17,250
-92% -$1.15M 0.01% 555
2026
Q1
$1.18M Buy
+18,735
New +$1.3M 0.22% 103
2025
Q4
Sell
-7
Closed -$471 2011
2025
Q3
$471 Sell
7
-49
-88% -$3.88K ﹤0.01% 1557
2025
Q2
$4.89K Sell
56
-1,431
-96% -$112K ﹤0.01% 1023
2025
Q1
$102K Buy
+1,487
New +$121K 0.08% 284

Other funds holding DXCM

Caitong International Asset Management's DXCM Position: Q2 2026 in Review

Caitong International Asset Management reduced its DexCom (DXCM) stake by 92% in Q2 2026, selling an estimated $1.15M and leaving 1,485 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #555.

Caitong International Asset Management first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.18M in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Caitong International Asset Management held 1,485 shares of DexCom worth $100K as of Q2 2026.
  • Caitong International Asset Management sold 17,250 DexCom shares in Q2 2026, an estimated $1.15M.
  • DexCom made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #555 holding.
  • Caitong International Asset Management first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's DexCom position peaked at $1.18M in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.